Cargando…

Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update

Non-alcoholic fatty liver disease and its related complications are becoming one of the most important health problems globally. The liver functions as both a metabolic and an immune organ. The crosstalk between hepatocytes and intrahepatic immune cells plays a key role in coordinating a dual functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Chu-Jun, Lo, Tak-Ho, Chan, Ka-Ying, Li, Xiang, Wu, Meng-Yao, Xiang, Zou, Wong, Chi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603875/ https://www.ncbi.nlm.nih.gov/pubmed/36293233 http://dx.doi.org/10.3390/ijms232012376

Ejemplares similares

Peroxiredoxin, Senescence, and Cancer
por: Wu, Mengyao, et al.
Publicado: (2022)

Role of Angiogenesis in the Pathogenesis of NAFLD
por: Lei, Lin, et al.
Publicado: (2021)

Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
por: Ohtani, Naoko, et al.
Publicado: (2023)

Role of NKT Cells in the Pathogenesis of NAFLD
por: Tajiri, Kazuto, et al.
Publicado: (2012)

Perturbation of the circadian clock and pathogenesis of NAFLD
por: Mukherji, Atish, et al.
Publicado: (2020)

The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
por: Vonderlin, Joscha, et al.
Publicado: (2023)

Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD
por: Song, Ming, et al.
Publicado: (2018)

The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
por: Östlund, Cecilia, et al.
Publicado: (2020)

Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis
por: Garcia-Martinez, Irma, et al.
Publicado: (2020)

The Emerging Role of B Cells in the Pathogenesis of NAFLD
por: Barrow, Fanta, et al.
Publicado: (2021)

Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD
por: An, Lingxuan, et al.
Publicado: (2023)

The role of NAFLD in cardiometabolic disease: an update
por: Faasse, Sarah, et al.
Publicado: (2018)

An Update on the Chemokine System in the Development of NAFLD
por: Nagata, Naoto, et al.
Publicado: (2022)

Environmental Pollution: A Tangible Risk for NAFLD Pathogenesis
por: Arciello, Mario, et al.
Publicado: (2013)

The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD
por: Zhou, Jin, et al.
Publicado: (2021)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

COVID-19 and MAFLD/NAFLD: An updated review
por: Nowroozi, Ali, et al.
Publicado: (2023)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scores
por: Yao, Renling, et al.
Publicado: (2021)

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Maternal Diet Alters Trained Immunity in the Pathogenesis of Pediatric NAFLD
por: Jonscher, Karen R., et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
por: Shao, Yaodi, et al.
Publicado: (2023)

NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis
por: Ma, Chi, et al.
Publicado: (2016)

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
por: Rada, Patricia, et al.
Publicado: (2020)

A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
por: Hossain, Newaz, et al.
Publicado: (2016)

Clinical trials using dental stem cells: 2022 update
por: Song, Wen-Peng, et al.
Publicado: (2023)

Clozapin-Update 2022
por: Qubad, Mishal, et al.
Publicado: (2022)

Tuberkulose – Update 2022
por: Kainz, Katharina, et al.
Publicado: (2023)

Caroli disease: an update on pathogenesis
por: Shi, Wen, et al.
Publicado: (2021)

Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)
por: Wu, Mengyao, et al.
Publicado: (2023)

Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies
por: Zhang, Xinyuan, et al.
Publicado: (2023)

The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications
por: Alisi, Anna, et al.
Publicado: (2017)

Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis
por: Zhao, Xu-Yun, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
por: Pafili, Kalliopi, et al.
Publicado: (2020)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

Update on the Pathogenesis of the Hirschsprung-Associated Enterocolitis
por: Li, Shuai, et al.
Publicado: (2023)

Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment
por: Wong, Lai-San, et al.
Publicado: (2022)

Environmental Epigenetics 2022 update
por: Skinner, Michael K
Publicado: (2022)

Fascial Nomenclature: Update 2022
por: Bordoni, Bruno, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ihftoqon8nmgpaodr1od26bdlo